Investors Target HSBC, IBM for Declines

By TENNILLE TRACY
June 28, 2008; Page B5

As the stock market sank to lows for the year, options traders couldn't help but seek companies that may be next in line for a beating.

In searching for potential victims, traders zeroed in on HSBC Holdings PLC and International Business Machines Corp.

Trading in HSBC options jumped Friday to eight times the normal daily volume. Investors picked up 70,000 puts, which let them sell the bank's stock, and 11,000 calls that allow them to buy it, according to Trade Alert.

Traders took up bearish up positions and flocked to September $75 puts, in particular, which were priced at $4.40 and make money if HSBC's American depositary shares fall below $70.60 before Sept. 19. Such a move would represent an 8% drop from Friday's close. The shares fell $1.39 to $76.55 as of 4 p.m. in New York Stock Exchange composite trading.

Although shares of the London bank have been more stable than those of some of HSBC's U.S. colleagues, traders wonder whether the company will unveil disappointing results or announce write-downs when it releases earnings Aug. 4.

"I think people may be watching to see if they get hit," said Scott Fullman, director of derivatives investment strategy at WJB Capital Group.

Option traders also appeared to be harboring concerns about IBM, picking up 53,000 puts and 30,000 calls.

With IBM preparing to release earnings on July 17 -- just one day before that month's options expire -- traders gravitated toward July $115 puts. Priced at $1.85, those contracts make money if IBM shares fall below $113.15 before July 18. The shares fell $1.08 to $120.05 on the NYSE.

Options traders pounced on IBM just days after Research in Motion Ltd. reported earnings and revenue that failed to meet Wall Street expectations. RIM's stock dropped 13% after the news, demonstrating how nervous investors are about the technology sector and the economy at large, said Rebecca Engmann Darst, an analyst at Interactive Brokers.

"Clearly, the economy is very dyspeptic, and that is going to bode very poorly for IBM," Ms. Darst said.